header-image_A-Z_700x150Single-Use Manufacturing Series

Innovations, Data, and Thought-Leadership

This series, will give you valuable insights into the efficiency of single-use for the biopharma industry - especially its manufacturing processes. You will discover the current marked business drivers and experience several related possibilities to overcome these challenges.

By combining knowledge and generating extensive expertise, Sartorius Stedim Biotech is developing solutions which take biopharmas a step closer to their ideal world in bioprocessing.

Watch out for Sartorius Stedim Biotech’s complete Single-Use Manufacturing Series throughout 2019 to access the latest information about the company’s’ technological capabilities, upcoming products and its innovations for process optimization.


 

Videocast: Potentials of Single-Use in Bioprocessing

The video provides a bite sized version of the podcast in which Stefan Schlack and Jean-Marc Cappia discuss their thoughts on the key drivers behind the challenges and opportunities currently facing the biopharma industry. Watch it now and If you enjoyed it but want to hear additional technical information and visionary predictions from both experts on these interesting topics, continue with the podcast.


SU-PR-special-Sartorius-Interview-191218-288

The Changing Landscape of Single Use in Bioprocessing: An Interview with Stefan Schlack and Jean-Marc Cappia

Single use in bioprocessing has changed significantly in recent years. To find out how a leading supplier to the biopharmaceutical industry is redefining its technology to align with new market challenges, science writer, Sue Pearson, had the opportunity to interview Stefan Schlack, Head of Bioprocess Marketing, and Jean-Marc Cappia, Head of Segment Marketing Vaccines, both at Sartorius Stedim Biotech (SSB) in Goettingen, Germany.
read-now_bpi

 


Podcast: The Changing Landscape of Single-Use in Bioprocessing

Sue Pearson, Science Writer in the Biopharma Industry, interviewed Stefan Schlack, Head of Bioprocess Marketing, and Jean-Marc Cappia, Head of Segment Marketing Vaccines former Head of Fluid Management Technologies at Sartorius Stedim Biotech about the changing landscape of single-use in bioprocessing. They discuss business drivers, currently developed facts and figures as well as upcoming solutions and visionary ideas.

 


 

Redefined from A – Z. Experience the change:

A_4zu3_01

B_4zu3_01

Automation Redefined.

Visionary platform technologies lead to high flexibility and prevent human errors. Benefit from our state-of-the-art automation technologies and configurable standardized solutions to experience the next step in robust production for your biologics.

Discover More

Biocompatibility Redefined.

Control of our materials and processes leads to consistent quality and safety of your biologics. Benefit from the excellent and reproducible extractables and particles profiles of our single-use solutions.

Discover More

I_4zu3_01

S_4zu3_01

Integrity Redefined.

Consistent robustness and Integrity testing lead to enhanced process integrity and patient safety. Benefit from our expertise in designing robust solutions, integrity testing science and technologies to de-risk your process from liquid leaks and microbial ingress.

Discover More

Supply Network Redefined.

A global manufacturing footprint along with end-to-end process control leads to strong assurance of quality supply. Benefit from high quality, robust change control and long-term business continuity through our unique supply network.

Discover More